PETALING JAYA: Analysts are cautious about Pentamaster Corp Bhd and its prospects within the industry.

In a report, Phillip Capital Research said after the third quarter of financial year 2026 briefing by the automation solution provider, it expects the firm’s 2027 growth to be supported by steady momentum in medical and artificial intelligence (AI) computing orders.

Currently, the group’s order book is split between factory automation solutions (FAS) at 65% and automated test equipment at 35%. Both are driven by medical (45%), AI compute (30%), consumer and industrial (10%), and automotive, opto- electronics and others at 5% each.

Its Campus 1 in Penang is running at full capacity, while Campus 3 is running between 60% to 70% with a 120,000 sq ft of expansion underway to accommodate growing FAS and Samurai equipment production ramps.

“Management is also exploring physical AI opportunities through a US startup customer targeting about one million units annually for domestic applications leveraging its iFlex platform, with potential revenue contribution from financial year 2027,” Phillip Capital said.

Pentamaster’s 9 Samurai series will be its main growth driver for next year, as AI compute is likely to scale from 24% of revenue in the first nine months of 2026 to about 50% in 2027, it added. This will be split evenly between Samurai and FAS.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.